PALI
PALISADE BIO, INC. · Healthcare · Market cap $244.0M
Insiders bought $29K net in the last 90 days ·0 sellers, 1 buyer· latest Form 4 filed Oct 5, 2026
Insider Buying
$297K
reported purchases (SEC code P)
Insider Selling
$420K
reported sales (SEC code S)
Unique Insiders
4
in the rolling window
Latest filing
Oct 21, 2026
Williams Donald Allen
PALISADE BIO, INC. (PALI) has 19 SEC Form 4 filings (34 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Oct 21, 2026.
Inside the rolling window, 4 insiders at PALISADE BIO, INC. reported 10 open-market purchases totaling $297K and 4 open-market sales totaling $420K. The most active filer is Director Baltera Robert Jr. with 6 filings. Insiders have net sold $131K over the trailing 6 months. The most recent open-market filing is a purchase of 10,000 shares by Director Williams Donald Allen, dated Oct 1, 2026, worth $14K.
- Industry:Biotechnology
- CEO:J. D. Finley
- Employees:14
- HQ:Denver, CA, US
- IPO:2007-03-30
| Source | |||||||
|---|---|---|---|---|---|---|---|
Williams Donald AllenFirst in 9 months | Director | Purchase | 10,000 | $14K | Oct 5 | -4.1% | SEC ↗ |
Williams Donald AllenFirst in 9 months | Director | Purchase | 10,000 | $15K | Oct 5 | -4.1% | SEC ↗ |
| Director | Purchase | 20,000 | $40K | Jul 10 | -28.6% | SEC ↗ | |
| Director | Purchase | 25,000 | $49K | Jul 10 | -28.6% | SEC ↗ | |
| Director | Purchase | 20,000 | $41K | Jul 8 | -31.7% | SEC ↗ | |
| Director | Purchase | 30,000 | $61K | Jul 8 | -31.7% | SEC ↗ | |
Jones Mitchell LawrenceFirst in 5 months | Chief Medical Officer | Sale | 51,880 | $107K | Jul 8 | -31.7% | SEC ↗ |
Finley John DavidFirst in 5 months | CEO, CFO | Sale | 146,798 | $303K | Jul 8 | -31.7% | SEC ↗ |
Baltera Robert Jr.First filing | Director | Purchase | 20,000 | $40K | Jul 6 | -31.4% | SEC ↗ |
Baltera Robert Jr.First filing | Director | Purchase | 10,000 | $20K | Jul 6 | -31.4% | SEC ↗ |
Finley John DavidFirst filing | CEO, CFO | Sale | 3,896 | $7K | Feb 13 | — | SEC ↗ |
Jones Mitchell LawrenceFirst filing | Chief Medical Officer | Sale | 1,989 | $3K | Feb 13 | — | SEC ↗ |
| Director | Purchase | 5,000 | $8K | Jan 21 | — | SEC ↗ | |
Williams Donald AllenFirst filing | Director | Purchase | 5,000 | $9K | Jan 13 | — | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does PALI have?
PALISADE BIO, INC. (PALI) has 19 SEC Form 4 filings (34 transaction rows) in the rolling 365-day window, disclosed by 4 distinct insiders. Most recent filing: Oct 21, 2026.
When was the most recent SEC Form 4 filing for PALI?
The most recent Form 4 filing for PALI on Tracefour is dated Oct 21, 2026.
Who is the most active insider at PALI?
The most active SEC Form 4 filer at PALI in the rolling window is Director Baltera Robert Jr., with 6 filings.
What is the net insider flow at PALI over the last 6 months?
Over the trailing 180 days, insiders at PALI have net sold $131K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at PALI in the current window?
Inside the rolling window, insiders at PALI bought $297K and sold $420K based on SEC Form 4 filings.
Can I get alerts for PALI insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at PALISADE BIO, INC. (PALI). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
PALISADE BIO, INC. is in the Healthcare sector.